SARS-CoV-2: Clinical Trials

1 trial for SARS-CoV-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow SARS-CoV-2: new trials by email Literature Review of SARS-CoV-2 trials Research Report on SARS-CoV-2

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
Placebo comparator, PRS CK STORM - SARS-CoV-2, Influenza, Human
Phase 1 / Phase 2RecruitingPEACHES BIOTECH502024-10-022026-06-10

Narrower conditions

COVID-19 (1)  ·  Cytokine Release Syndrome (1)  ·  Influenza, Human (1)  ·  Lung Diseases (1)  ·  Pneumonia (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Syncytial Virus Infections (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Mononegavirales Infections (1)  ·  Nidovirales Infections (1)  ·  Orthomyxoviridae Infections (1)  ·  Paramyxoviridae Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia, Viral (1)  ·  Pneumovirus Infections (1)  ·  RNA Virus Infections (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)

Interventions

Saline Solution (1)

Sponsors

PEACHES BIOTECH (1)

Countries

Spain (1)

Top investigators

David Bernal, Dr. (1)

Results publications

PMID 35454123

NIH funding

2023 (1)